Approval Year
| Substance Class |
Protein
Created
by
admin
on
Edited
Mon Mar 31 20:36:53 GMT 2025
by
admin
on
Mon Mar 31 20:36:53 GMT 2025
|
| Protein Type | MONOCLONAL ANTIBODY CONJUGATE |
| Protein Sub Type | IGG1 |
| Sequence Origin | HUMANIZED MOUSE |
| Sequence Type | COMPLETE |
| Record UNII |
7Z7EUX7R6M
|
| Record Status |
Validated (UNII)
|
| Record Version |
|
-
Download
| Name | Type | Language | ||
|---|---|---|---|---|
|
Preferred Name | English | ||
|
Official Name | English | ||
|
Common Name | English | ||
|
Common Name | English | ||
|
Common Name | English | ||
|
Common Name | English | ||
|
Code | English | ||
|
Common Name | English | ||
|
Common Name | English | ||
|
Code | English | ||
|
Common Name | English | ||
|
Code | English |
| Classification Tree | Code System | Code | ||
|---|---|---|---|---|
|
NCI_THESAURUS |
C20401
Created by
admin on Mon Mar 31 20:36:53 GMT 2025 , Edited by admin on Mon Mar 31 20:36:53 GMT 2025
|
||
|
FDA ORPHAN DRUG |
138400
Created by
admin on Mon Mar 31 20:36:53 GMT 2025 , Edited by admin on Mon Mar 31 20:36:53 GMT 2025
|
| Code System | Code | Type | Description | ||
|---|---|---|---|---|---|
|
300000025311
Created by
admin on Mon Mar 31 20:36:53 GMT 2025 , Edited by admin on Mon Mar 31 20:36:53 GMT 2025
|
PRIMARY | |||
|
CHEMBL1742997
Created by
admin on Mon Mar 31 20:36:53 GMT 2025 , Edited by admin on Mon Mar 31 20:36:53 GMT 2025
|
PRIMARY | |||
|
7Z7EUX7R6M
Created by
admin on Mon Mar 31 20:36:53 GMT 2025 , Edited by admin on Mon Mar 31 20:36:53 GMT 2025
|
PRIMARY | |||
|
8223
Created by
admin on Mon Mar 31 20:36:53 GMT 2025 , Edited by admin on Mon Mar 31 20:36:53 GMT 2025
|
PRIMARY | |||
|
C483240
Created by
admin on Mon Mar 31 20:36:53 GMT 2025 , Edited by admin on Mon Mar 31 20:36:53 GMT 2025
|
PRIMARY | |||
|
C95782
Created by
admin on Mon Mar 31 20:36:53 GMT 2025 , Edited by admin on Mon Mar 31 20:36:53 GMT 2025
|
PRIMARY | |||
|
NN-18
Created by
admin on Mon Mar 31 20:36:53 GMT 2025 , Edited by admin on Mon Mar 31 20:36:53 GMT 2025
|
PRIMARY | |||
|
400010-39-1
Created by
admin on Mon Mar 31 20:36:53 GMT 2025 , Edited by admin on Mon Mar 31 20:36:53 GMT 2025
|
PRIMARY | |||
|
Cantuzumab mertansine
Created by
admin on Mon Mar 31 20:36:53 GMT 2025 , Edited by admin on Mon Mar 31 20:36:53 GMT 2025
|
PRIMARY |
| From | To |
|---|---|
| 1_22 | 1_96 |
| 2_22 | 2_96 |
| 3_23 | 3_93 |
| 4_23 | 4_93 |
| 3_139 | 3_199 |
| 4_139 | 4_199 |
| 1_146 | 1_202 |
| 2_146 | 2_202 |
| 1_222 | 3_219 |
| 2_222 | 4_219 |
| 1_228 | 2_228 |
| 1_231 | 2_231 |
| 1_263 | 1_323 |
| 2_263 | 2_323 |
| 1_369 | 1_427 |
| 2_369 | 2_427 |
| Glycosylation Link Type | Site |
|---|---|
| N | 1_299 |
| N | 2_299 |
| Related Record | Type | Details | ||
|---|---|---|---|---|
|
TARGET->LIGAND |
| Related Record | Type | Details | ||
|---|---|---|---|---|
|
|
ACTIVE MOIETY |
Structural Modifications
| Modification Type | Location Site | Location Type | Residue Modified | Extent | Fragment Name | Fragment Approval |
|---|---|---|---|---|---|---|
| AMINO_ACID_SUBSTITUTION | [1_1] [2_1] |
Amount:
|
PIDOLIC ACID | SZB83O1W42 | ||
| AMINO_ACID_SUBSTITUTION | RESIDUE_SPECIFIC | K |
Amount:
|
MERTANSINE N6-LYSYL-4-SULFANYLPENTANAMIDE DISULFIDE | 3QN0K2A6Q8 |
| Name | Property Type | Amount | Referenced Substance | Defining | Parameters | References |
|---|---|---|---|---|---|---|
| Molecular Formula | CHEMICAL |
|
||||
| MOL_WEIGHT:NUMBER(CALCULATED) | CHEMICAL |
|